DE | Accessible presentation
Translations are powered by AI

The most important investments of the first quarter of 2024

Tubulis, Finn, Robco – numerous startups from Munich and the surrounding area successfully raised funding in the first quarter of this year. The photo gallery provides an overview of the largest investments in the first quarter of 2024.

April 3, 2024 2 min reading time

Tubules
Tubulis increases Series B to 128 million euros: Tubulis is working on special antibody-drug conjugates for cancer therapy. The Munich-based biotech company has now completed an expanded and oversubscribed Series B2 financing round of 128 million euros EQT Life Sciences and Nextech Invest Ltd are leading the round. Numerous existing investors are also participating, including Bayern Kapital, Biomedpartners, Coparion, High-Tech Gründerfonds (HTGF), Occident, and Seventure Partners. Two new US investors are also participating: Frazier Life Sciences and Deep Track Capital. Tubulis intends to use the funds from the current financing round to complete the initial clinical evaluation of two drug candidates and further develop its own technology platform. (Image: Tubulis)
read more ↓